Acorah Software Products - Accounts Production 19.4.351 false true false true No description of principal activity 5 November 2025 30 September 2026 30 September 2026 16833957 Mr Klodian Gica iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16833957 2025-11-04 16833957 2026-09-30 16833957 2025-11-05 2026-09-30 16833957 frs-core:CurrentFinancialInstruments 2026-09-30 16833957 frs-bus:PrivateLimitedCompanyLtd 2025-11-05 2026-09-30 16833957 frs-bus:FilletedAccounts 2025-11-05 2026-09-30 16833957 frs-bus:Micro-entities 2025-11-05 2026-09-30 16833957 frs-bus:AuditExempt-NoAccountantsReport 2025-11-05 2026-09-30 16833957 frs-bus:Director1 2025-11-05 2026-09-30
Registered number: 16833957
Nad Medi Care Limited
Unaudited Financial Statements
For the Period 5 November 2025 to 30 September 2026
PC2 Accountancy Limited
2 Fountain Court
Victoria Square
St Albans
AL1 3TF
Balance Sheet
Registered number: 16833957
30 September 2026
£
Current assets 307
Creditors: Amounts Falling Due Within One Year (6,456 )
NET CURRENT LIABILITIES (6,149 )
TOTAL ASSETS LESS CURRENT LIABILITIES (6,149 )
Accruals and deferred income (1,620 )
NET LIABILITIES (7,769 )
CAPITAL AND RESERVES (7,769 )

Notes

1. General Information
Nad Medi Care Limited is a private company, limited by shares, incorporated in England & Wales, registered number 16833957 . The registered office is 103 Charing Cross Road, 1st Floor, London, WC2H 0DT.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 30 September 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Klodian Gica
Director
08/10/2026